Pure Global Cannabis Inc. Share Price Toronto S.E.
Equities
PURE.H
CA74625A1075
Pharmaceuticals
Sales 2017 | - | Sales 2018 | - | Capitalization | 24.16M 33.02M 2.02B |
---|---|---|---|---|---|
Net income 2017 | - 0 0 | Net income 2018 | -23M -31.44M -1.92B | EV / Sales 2017 * | - |
Net Debt 2017 | 211K 288K 17.61M | Net Debt 2018 | 4.49M 6.14M 375M | EV / Sales 2018 | - |
P/E ratio 2017 * |
-
| P/E ratio 2018 |
-0.72
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 83.64% |
Managers | Title | Age | Since |
---|---|---|---|
Vik Chopra
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjeev Goel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Lavergne
PRN | Corporate Officer/Principal | - | 30/18/30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jane E. Pagel
BRD | Director/Board Member | - | 01/18/01 |
1st Jan change | Capi. | |
---|---|---|
+40.09% | 6.16B | |
-16.34% | 4.46B | |
-7.11% | 3.27B | |
+5.14% | 3.2B | |
-0.18% | 2.6B | |
+47.93% | 1.98B | |
-7.15% | 1.7B | |
+0.67% | 1.66B | |
-8.73% | 1.61B |